SG11202102108QA - Methods for mass spectrometry analysis of engineered cell compositions - Google Patents
Methods for mass spectrometry analysis of engineered cell compositionsInfo
- Publication number
- SG11202102108QA SG11202102108QA SG11202102108QA SG11202102108QA SG11202102108QA SG 11202102108Q A SG11202102108Q A SG 11202102108QA SG 11202102108Q A SG11202102108Q A SG 11202102108QA SG 11202102108Q A SG11202102108Q A SG 11202102108QA SG 11202102108Q A SG11202102108Q A SG 11202102108QA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- mass spectrometry
- engineered cell
- spectrometry analysis
- cell compositions
- Prior art date
Links
- 238000004949 mass spectrometry Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862729985P | 2018-09-11 | 2018-09-11 | |
PCT/US2019/050681 WO2020056047A1 (en) | 2018-09-11 | 2019-09-11 | Methods for mass spectrometry analysis of engineered cell compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202102108QA true SG11202102108QA (en) | 2021-04-29 |
Family
ID=68136527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202102108QA SG11202102108QA (en) | 2018-09-11 | 2019-09-11 | Methods for mass spectrometry analysis of engineered cell compositions |
Country Status (14)
Country | Link |
---|---|
US (1) | US20220050114A1 (en) |
EP (1) | EP3850366A1 (en) |
JP (1) | JP2022500674A (en) |
KR (1) | KR20210081341A (en) |
CN (1) | CN113167796A (en) |
AU (1) | AU2019339464A1 (en) |
BR (1) | BR112021004261A2 (en) |
CA (1) | CA3111789A1 (en) |
EA (1) | EA202190693A1 (en) |
IL (1) | IL281325A (en) |
MA (1) | MA53612A (en) |
MX (1) | MX2021002574A (en) |
SG (1) | SG11202102108QA (en) |
WO (1) | WO2020056047A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110709700A (en) | 2017-04-14 | 2020-01-17 | 朱诺治疗学股份有限公司 | Method for evaluating cell surface glycosylation |
CN116981680A (en) * | 2021-01-14 | 2023-10-31 | 生物催化剂有限责任公司 | Compositions and methods for peptide production |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4452773A (en) | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
JP2624470B2 (en) | 1984-10-02 | 1997-06-25 | バイオジェン インコーポレイテッド | Production of streptavidin-like polypeptide |
US4795698A (en) | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
ES2067018T3 (en) | 1988-12-28 | 1995-03-16 | Stefan Miltenyi | PROCEDURE AND MATERIALS FOR THE SEPARATION IN HIGH MAGNETIC GRADIENT OF BIOLOGICAL MATERIALS. |
US5200084A (en) | 1990-09-26 | 1993-04-06 | Immunicon Corporation | Apparatus and methods for magnetic separation |
DE4123760C2 (en) | 1991-07-18 | 2000-01-20 | Dade Behring Marburg Gmbh | Seroreactive areas on the HPV 16 proteins E1 and E2 |
DE4228458A1 (en) | 1992-08-27 | 1994-06-01 | Beiersdorf Ag | Multicistronic expression units and their use |
DE4237113B4 (en) | 1992-11-03 | 2006-10-12 | "Iba Gmbh" | Peptides and their fusion proteins, expression vector and method of producing a fusion protein |
US5827642A (en) | 1994-08-31 | 1998-10-27 | Fred Hutchinson Cancer Research Center | Rapid expansion method ("REM") for in vitro propagation of T lymphocytes |
WO1996013593A2 (en) | 1994-10-26 | 1996-05-09 | Procept, Inc. | Soluble single chain t cell receptors |
WO1996018105A1 (en) | 1994-12-06 | 1996-06-13 | The President And Fellows Of Harvard College | Single chain t-cell receptor |
US5840306A (en) | 1995-03-22 | 1998-11-24 | Merck & Co., Inc. | DNA encoding human papillomavirus type 18 |
US20020150914A1 (en) | 1995-06-30 | 2002-10-17 | Kobenhavns Universitet | Recombinant antibodies from a phage display library, directed against a peptide-MHC complex |
DE19608753C1 (en) | 1996-03-06 | 1997-06-26 | Medigene Gmbh | Transduction system based on rep-negative adeno-associated virus vector |
US6451995B1 (en) | 1996-03-20 | 2002-09-17 | Sloan-Kettering Institute For Cancer Research | Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods |
DE69605062T2 (en) | 1996-04-24 | 2000-07-13 | Claude Fell | CELL SEPARATION DEVICE FOR BIOLOGICAL LIQUIDS LIKE BLOOD |
DE19641876B4 (en) | 1996-10-10 | 2011-09-29 | Iba Gmbh | streptavidin muteins |
KR100712256B1 (en) | 1997-10-02 | 2007-04-27 | 알토 바이오사이언스 코포레이션 | Soluble single-chain T-cell receptor proteins |
EA200001216A1 (en) | 1998-05-19 | 2001-06-25 | Авидекс Лимитед | SOLUBLE T-LYMPHOCYTIC RECEPTOR |
WO2000014257A1 (en) | 1998-09-04 | 2000-03-16 | Sloan-Kettering Institute For Cancer Research | Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
WO2000023573A2 (en) | 1998-10-20 | 2000-04-27 | City Of Hope | Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
US6733433B1 (en) | 1998-12-24 | 2004-05-11 | Biosafe S.A. | Blood separation system particularly for concentrating hematopoietic stem cells |
US20040191260A1 (en) | 2003-03-26 | 2004-09-30 | Technion Research & Development Foundation Ltd. | Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof |
US20020131960A1 (en) | 2000-06-02 | 2002-09-19 | Michel Sadelain | Artificial antigen presenting cells and methods of use thereof |
WO2002077029A2 (en) | 2000-11-07 | 2002-10-03 | City Of Hope | Cd19-specific redirected immune cells |
EP1227321A1 (en) | 2000-12-28 | 2002-07-31 | Institut für Bioanalytik GmbH | Reversible MHC multimer staining for functional purification of antigen-specific T cells |
DE10113776B4 (en) | 2001-03-21 | 2012-08-09 | "Iba Gmbh" | Isolated streptavidin-binding, competitively elutable peptide, this comprehensive fusion peptide, nucleic acid coding therefor, expression vector, methods for producing a recombinant fusion protein and methods for detecting and / or obtaining the fusion protein |
US7070995B2 (en) | 2001-04-11 | 2006-07-04 | City Of Hope | CE7-specific redirected immune cells |
US20090257994A1 (en) | 2001-04-30 | 2009-10-15 | City Of Hope | Chimeric immunoreceptor useful in treating human cancers |
IL160359A0 (en) | 2001-08-31 | 2004-07-25 | Avidex Ltd | Soluble t cell receptor |
US7939059B2 (en) | 2001-12-10 | 2011-05-10 | California Institute Of Technology | Method for the generation of antigen-specific lymphocytes |
US6992176B2 (en) | 2002-02-13 | 2006-01-31 | Technion Research & Development Foundation Ltd. | Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
US20030223994A1 (en) | 2002-02-20 | 2003-12-04 | Hoogenboom Henricus Renerus Jacobus Mattheus | MHC-peptide complex binding ligands |
US7446190B2 (en) | 2002-05-28 | 2008-11-04 | Sloan-Kettering Institute For Cancer Research | Nucleic acids encoding chimeric T cell receptors |
JP4436319B2 (en) | 2002-10-09 | 2010-03-24 | メディジーン リミテッド | Single-chain recombinant T cell receptor |
US20050129671A1 (en) | 2003-03-11 | 2005-06-16 | City Of Hope | Mammalian antigen-presenting T cells and bi-specific T cells |
US20090226474A1 (en) | 2004-05-27 | 2009-09-10 | Weidanz Jon A | Antibodies as T cell receptor mimics, methods of production and uses thereof |
US20090304679A1 (en) | 2004-05-27 | 2009-12-10 | Weidanz Jon A | Antibodies as T cell receptor mimics, methods of production and uses thereof |
CA2567814C (en) | 2004-05-27 | 2013-07-23 | Jon A. Weidanz | Antibodies as t cell receptor mimics, methods of production and uses thereof |
WO2006000830A2 (en) | 2004-06-29 | 2006-01-05 | Avidex Ltd | Cells expressing a modified t cell receptor |
AU2005291039A1 (en) | 2004-10-01 | 2006-04-13 | Avidex Ltd. | T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
JP4846782B2 (en) | 2005-03-23 | 2011-12-28 | ビオセフ エス・アー | Integrated system for collecting, processing and transplanting cell subsets including adult stem cells for regenerative medicine |
WO2008120203A2 (en) | 2007-03-29 | 2008-10-09 | Technion Research & Development Foundation Ltd. | Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases |
HUE038506T2 (en) | 2007-03-30 | 2018-10-29 | Memorial Sloan Kettering Cancer Center | Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes |
EP2433713B1 (en) | 2007-12-07 | 2017-07-26 | Miltenyi Biotec GmbH | Cell processing systems and methods |
US8479118B2 (en) | 2007-12-10 | 2013-07-02 | Microsoft Corporation | Switching search providers within a browser search box |
US20120164718A1 (en) | 2008-05-06 | 2012-06-28 | Innovative Micro Technology | Removable/disposable apparatus for MEMS particle sorting device |
JP5173594B2 (en) | 2008-05-27 | 2013-04-03 | キヤノン株式会社 | Management apparatus, image forming apparatus, and processing method thereof |
WO2011044186A1 (en) | 2009-10-06 | 2011-04-14 | The Board Of Trustees Of The University Of Illinois | Human single-chain t cell receptors |
SI2496698T1 (en) | 2009-11-03 | 2019-07-31 | City Of Hope | TRUNCATED EPIDERIMAL GROWTH FACTOR RECEPTOR (EGFRt) FOR TRANSDUCED T CELL SELECTION |
SG177025A1 (en) | 2010-06-21 | 2012-01-30 | Agency Science Tech & Res | Hepatitis b virus specific antibody and uses thereof |
JP5947311B2 (en) | 2010-12-09 | 2016-07-06 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Use of chimeric antigen receptor modified T cells for the treatment of cancer |
CA2821080C (en) | 2010-12-14 | 2021-02-02 | University Of Maryland, Baltimore | Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer |
MX359513B (en) | 2011-03-23 | 2018-10-01 | Hutchinson Fred Cancer Res | METHOD and COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY. |
SG193956A1 (en) | 2011-04-01 | 2013-11-29 | Sloan Kettering Inst Cancer | T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2 |
US8398282B2 (en) | 2011-05-12 | 2013-03-19 | Delphi Technologies, Inc. | Vehicle front lighting assembly and systems having a variable tint electrowetting element |
CN103797028B (en) | 2011-07-18 | 2017-08-25 | Iba 股份有限公司 | Make the method for the reversible dyeing of target cell |
CN108947885A (en) | 2011-09-28 | 2018-12-07 | 沃特世科技公司 | The glycan of MS signal with enhancing and the rapid fluorescence label of other biomolecule |
CN107011426B (en) | 2011-11-11 | 2021-05-14 | 弗雷德哈钦森癌症研究中心 | T cell immunotherapy targeting cyclin A1 against cancer |
EP2814846B1 (en) | 2012-02-13 | 2020-01-08 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
WO2013126726A1 (en) | 2012-02-22 | 2013-08-29 | The Trustees Of The University Of Pennsylvania | Double transgenic t cells comprising a car and a tcr and their methods of use |
CN104254780B (en) | 2012-02-23 | 2017-04-12 | 朱诺治疗有限公司 | Chromatographic isolation of cells and other complex biological materials |
NZ702108A (en) | 2012-05-03 | 2016-09-30 | Hutchinson Fred Cancer Res | Enhanced affinity t cell receptors and methods for making the same |
RU2700765C2 (en) | 2012-08-20 | 2019-09-19 | Фред Хатчинсон Кансэр Рисёч Сентер | Method and compositions for cell immunotherapy |
EP3597215A1 (en) | 2012-10-02 | 2020-01-22 | Memorial Sloan-Kettering Cancer Center | Compositions and methods for immunotherapy |
US10065996B2 (en) | 2012-11-16 | 2018-09-04 | Iba Gmbh | Streptavidin muteins and methods of using them |
DE112012007250T5 (en) | 2012-12-20 | 2015-10-08 | Mitsubishi Electric Corp. | Vehicle internal device and program |
EP4137564A1 (en) | 2013-07-15 | 2023-02-22 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Methods of preparing anti-human papillomavirus antigen t cells |
CA2918216C (en) | 2013-07-15 | 2023-03-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-human papillomavirus 16 e6 t cell receptors |
US9108442B2 (en) | 2013-08-20 | 2015-08-18 | Ricoh Company, Ltd. | Image forming apparatus |
US11400115B2 (en) | 2014-04-23 | 2022-08-02 | Juno Therapeutics, Inc. | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy |
WO2015168613A2 (en) | 2014-05-02 | 2015-11-05 | The Trustees Of The University Of Pennsylvania | Compositions and methods of chimeric autoantibody receptor t cells |
WO2015184228A1 (en) | 2014-05-29 | 2015-12-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-human papillomavirus 16 e7 t cell receptors |
ES2688035T3 (en) | 2014-08-29 | 2018-10-30 | Gemoab Monoclonals Gmbh | Universal antigen receptor that expresses immune cells for addressing multiple multiple antigens, procedure for manufacturing it and using it for the treatment of cancer, infections and autoimmune diseases |
IL292450A (en) | 2014-11-05 | 2022-06-01 | Juno Therapeutics Inc | Methods for transduction and cell processing |
WO2018027197A1 (en) * | 2016-08-04 | 2018-02-08 | Memorial Sloan-Kettering Cancer Center | Cancer antigen targets and uses thereof |
BR112019017767A2 (en) | 2017-02-27 | 2020-04-07 | Juno Therapeutics Inc | compositions, articles of manufacture and methods related to dosing in cell therapy |
-
2019
- 2019-09-11 MX MX2021002574A patent/MX2021002574A/en unknown
- 2019-09-11 EP EP19782815.5A patent/EP3850366A1/en active Pending
- 2019-09-11 CA CA3111789A patent/CA3111789A1/en active Pending
- 2019-09-11 WO PCT/US2019/050681 patent/WO2020056047A1/en unknown
- 2019-09-11 AU AU2019339464A patent/AU2019339464A1/en active Pending
- 2019-09-11 BR BR112021004261-0A patent/BR112021004261A2/en unknown
- 2019-09-11 KR KR1020217010583A patent/KR20210081341A/en active Search and Examination
- 2019-09-11 MA MA053612A patent/MA53612A/en unknown
- 2019-09-11 SG SG11202102108QA patent/SG11202102108QA/en unknown
- 2019-09-11 CN CN201980073541.8A patent/CN113167796A/en active Pending
- 2019-09-11 JP JP2021538180A patent/JP2022500674A/en active Pending
- 2019-09-11 EA EA202190693A patent/EA202190693A1/en unknown
- 2019-09-11 US US17/274,770 patent/US20220050114A1/en active Pending
-
2021
- 2021-03-08 IL IL281325A patent/IL281325A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL281325A (en) | 2021-04-29 |
WO2020056047A1 (en) | 2020-03-19 |
AU2019339464A1 (en) | 2021-03-25 |
EP3850366A1 (en) | 2021-07-21 |
BR112021004261A2 (en) | 2021-05-25 |
CN113167796A (en) | 2021-07-23 |
US20220050114A1 (en) | 2022-02-17 |
CA3111789A1 (en) | 2020-03-19 |
KR20210081341A (en) | 2021-07-01 |
EA202190693A1 (en) | 2021-07-27 |
JP2022500674A (en) | 2022-01-04 |
MA53612A (en) | 2021-09-15 |
MX2021002574A (en) | 2021-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2552602B (en) | Desorption electrospray ionisation mass spectrometry ("DESI-MS") analysis of swabs | |
GB2575339B (en) | Multi-reflecting time of flight mass analyser | |
GB201715767D0 (en) | Tissue analysis by mass spectrometry or ion mobility spectrometry | |
GB2575157B (en) | Multi-reflecting time of flight mass analyser | |
LT3263715T (en) | Method for transcriptome analysis of single cells | |
GB2563604B (en) | Mass spectrometer and method for time-of-flight mass spectrometry | |
GB2554206B (en) | Spectrometric analysis of microbes | |
EP3304090A4 (en) | Correlated peptides for quantitative mass spectrometry | |
IL286945A (en) | Methods and compositions for analyzing nucleic acid | |
SG10202111266VA (en) | Compositions and methods for library construction and sequence analysis | |
EP3160609A4 (en) | Automated sample fractionation prior to mass spectrometric analysis | |
EP3310719A4 (en) | Compositions and methods for analytical sample preparation | |
EP3155416A4 (en) | Methods for analysis of lipids using mass spectrometry | |
EP3274719A4 (en) | Single cell analysis using secondary ion mass spectrometry | |
HK1253726A1 (en) | Reagents for quantitative mass spectrometry | |
EP3115778A4 (en) | Method of mass spectrometry and mass spectrometer | |
GB2590601B (en) | Method of mass spectrometry | |
GB2576836B (en) | Compositions and methods for multiplexed quantitative analysis of cell lineages | |
GB201809552D0 (en) | Mass spectrometry screening method | |
GB2562858B (en) | Method for the cytometric analysis of cell samples | |
IL281325A (en) | Methods for mass spectrometry analysis of engineered cell compositions | |
IL274839A (en) | Compositions and methods for the depletion of cd5(plus) cells | |
IL288411A (en) | Using mass spectrometry to identify endometriosis tissue | |
EP3756014A4 (en) | Tissue analysis by mass spectrometry | |
GB202205043D0 (en) | Analysis of Isomers in TIMS-Q-Q-TOF mass spectrometers |